AngioDynamics Revenue and Competitors
Estimated Revenue & Valuation
- AngioDynamics's estimated annual revenue is currently $297.8M per year.
- AngioDynamics's estimated revenue per employee is $315,424
- AngioDynamics's total funding is $9M.
- AngioDynamics's current valuation is $874.7M. (January 2022)
Employee Data
- AngioDynamics has 944 Employees.
- AngioDynamics grew their employee count by 0% last year.
AngioDynamics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Sr. VP, GM, Global Vascular Interventional & Therapies | Reveal Email/Phone |
2 | Regional VP Commercial Operations & Business Development | Reveal Email/Phone |
3 | VP, Global Procurement | Reveal Email/Phone |
4 | VP, IT Enterprise Systems | Reveal Email/Phone |
5 | VP, Research and Development | Reveal Email/Phone |
6 | SVP, Global Operations and R&D | Reveal Email/Phone |
7 | SVP, Quality & Regulatory Affairs | Reveal Email/Phone |
8 | VP Sales, Endovascular Therapies | Reveal Email/Phone |
9 | SVP, Business Development | Reveal Email/Phone |
10 | SVP IT | Reveal Email/Phone |
AngioDynamics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $352.6M | 878 | 6% | $323.5M | N/A |
#2 | $9.3M | 37 | 12% | N/A | N/A |
#3 | $36.4M | 145 | 2% | N/A | N/A |
#4 | $7M | 28 | 0% | N/A | N/A |
#5 | $1M | 4 | -88% | N/A | N/A |
#6 | $7.5M | 21 | -9% | $6.5M | N/A |
#7 | $6M | 24 | 4% | N/A | N/A |
#8 | $13.1M | 52 | 4% | N/A | N/A |
#9 | $17.1M | 68 | -17% | N/A | N/A |
#10 | $27.9M | 111 | 4% | N/A | N/A |
What Is AngioDynamics?
AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, vascular surgeons and other physicians for the minimally invasive diagnosis and treatment of peripheral vascular disease. AngioDynamics designs, develops, manufactures and markets a broad line of therapeutic and diagnostic devices that enable interventional physicians, such as interventional radiologists, vascular surgeons and others, to treat peripheral vascular diseases and other non-coronary diseases. The company's diverse product line includes angiographic products and accessories, dialysis products, vascular access products, PTA products, drainage products, thrombolytic products and venous products.
keywords:N/A
$9M
Total Funding
944
Number of Employees
$297.8M
Revenue (est)
0%
Employee Growth %
$874.7M
Valuation
N/A
Accelerator
AngioDynamics News
AngioDynamics's revenue for the quarter was up 3.9% on a year-over-year basis. Equities research analysts expect that AngioDynamics will post -...
In this news release, AngioDynamics has reported adjusted EBITDA, adjusted net income and adjusted earnings per share. Management uses these...
AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system...
Study Will Assess Use of NanoKnife System in Prostate Tissue Ablation Latham, New York, August 11, 2021 - AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, has received approva ...
AngioDynamics, Inc. (NASDAQ: ANGO), a Latham, NY-based provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, acquired Eximo Medical, Ltd., a Rehovot, Israel-based early commercial stage, medical device company, and its propriet ...
Other Companies in Latham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $75M | 1671 | 8% | N/A |
#2 | $300M | 2237 | 8% | $5.4B |